Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz, a First-in-Market Biosimilar to Simponi (golimumab)
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global…
Big Pharma Has Spent Nearly $150 Billion On M&A (So Far) In 2025
In this week's edition of InnovationRx, we look at the biotech deal frenzy, Recursion's incoming CEO, the infant formula botulism outbreak, and more. To get it in your inbox, subscribe here. Merck announced last week that it would acquire biotech…
US pharma ramps up attack on Australia's 'discriminatory' drug pricing
The US pharmaceutical industry is increasing pressure on Donald Trump to take action against the Pharmaceutical Benefits Scheme, which it says makes Australia one of the most difficult countries in the world to get new medicines approved and…
Purdue Pharma, We Will See You In Hell!
A bankruptcy judge says he will make it official: Purdue Pharma — in business in some form since 1892 and wholly owned by members of the Sackler family since 1952 — shall soon be no more, dissolved, and it and its soon-to-be-former…
Agios Pharma: Study Fail May Affect Mitapivat TDT Approval - Expect More Volatility (AGIO)
Agios Pharmaceuticals, Inc. stock plunged 49% after mixed Phase 3 results for mitapivat in Sickle Cell Disease, raising doubts about future approvals. Mitapivat met the primary hemoglobin endpoint but failed to significantly reduce pain crises or…
ACA Pharma Announces 2026 China NPP Group Procurement Priority List for Orphan and Clinically Urgent Drugs
'China's pediatric and rare-disease hospitals are telling us clearly which therapies they need most, and our job is to turn those requests into practical, compliant access pathways,' said Mike Zhou, CEO, ACA Pharma. 'By combining group NPP access…
Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
AI chip maker Nvidia's fresh partnerships with Eli Lilly and Johnson & Johnson point to a broader trend in the pharmaceutical industry, where tie-ups with AI giants are intended to speed up drug discovery and make work easier for health care…
BridgeBio Pharma (NASDAQ:BBIO) CFO Sells $1,125,433.64 in Stock
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CFO Thomas Trimarchi sold 16,934 shares of the stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $66.46, for a total transaction of $1,125,433.64.
BridgeBio Pharma, Inc. $BBIO Shares Sold by KBC Group NV
KBC Group NV lowered its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 98.0% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 4,195 shares of the company's stock after selling…
Urogen Pharma (NASDAQ:URGN) Reaches New 52-Week High - What's Next?
Urogen Pharma (NASDAQ:URGN - Get Free Report)'s stock price reached a new 52-week high on Thursday. The company traded as high as $25.60 and last traded at $25.27, with a volume of 2384324 shares changing hands. The stock had previously closed at…
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Consensus Recommendation of 'Hold' by Analysts
Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have received an average recommendation of 'Hold' from the eight brokerages that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a…
Savant Capital LLC Acquires Shares of 5,051 BridgeBio Pharma, Inc. $BBIO
Savant Capital LLC bought a new position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 5,051 shares…
Intech Investment Management LLC Increases Stock Position in BridgeBio Pharma, Inc. $BBIO
Intech Investment Management LLC lifted its stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 19.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 87,880…
Switzerland releases further CHF50 million Sudan aid
The situation for the civilian population of Sudan and the region has worsened following the capture of the town of El-Fasher by the paramilitary Rapid Support Forces, in the conflict that has pitted them against Sudan's regular armed forces since…
Switzerland misses transalpine freight targets
The access routes are slowing down. The Federal Council is therefore lobbying neighbouring countries for rapid modernisation. The modal shift target of 650,000 lorry journeys set out in the Alpine Initiative adopted in 1994 was also exceeded in…
Receive a Daily briefing on Pharma Industry News
Get Started